Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Closure

MY.10 -- A Randomized Phase III Study of Thalidomide and Prednisone as Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma -- will close to accrual today at 6pm EST.
http://www.ctg.queensu.ca/trials/hematologic/my10/my10.html